Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Opio
    Member
    • Oct 2017
    • 10

    #1

    Huge differences in variant calling between ExAC and 1000G

    Hi,

    I just performed my first variant calling on a Whole Exome Sequencing on 2 patients.
    I did the pipeline following the recommendations and good practice from GATK, and at the end, with a MAF of ~2-3% (I tried both) on 1000G and an inhouse vcf, I have for some gene a huge difference between 1000G that gives me a frequency of 0.004 for a gene (MUC6) and for the same ExAC in NFE gives me a 0.4. So that's huge.

    How can this difference could be possible?
    I looked for databases in internet and also in databases in txt to look for any errors, but it seems not very relevant.

    It is something sometimes happening?
    What is the credibility of that kind of measures? One database says "rare enough" and the other one says " common" !

    Best,
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    https://www.biostars.org/p/109425/

    Comment

    • Opio
      Member
      • Oct 2017
      • 10

      #3
      Hi Bukowski, thanks, we talked a bit about that in the group and I learned recently that it is highly polymorphic.
      Still though, how can this be possible to have 0.004 in a database and 0.4 on the other one? It's comparing 40% versus 0.4% ! That's more about that part that I have troubles.
      How ExAC and 1000G are built to have such differences in their references?

      best,

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...